Article
Recurrent hepatitis C after liver transplantation: on-treatment prediction of response to peginterferon/ribavirin therapy.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society - 1 Jan 2008
Hanouneh Ibrahim A, Miller Charles, Aucejo Federico, Lopez Rocio, Quinn Mary Kay, Zein Nizar N
Abstract excerpt
Sustained virologic response (SVR) in the treatment of recurrent hepatitis C virus (HCV) infection after liver transplantation (LT) remains suboptimal. We evaluated efficacy of pegylated interferon alfa (PEG) and ribavirin (RBV) (PEG/RBV) combination therapy in LT recipients with recurrent HCV and predictive values of rapid virological response (RVR) and early virologic response (EVR). Between January 2001 and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
